Please assess the completion status of the following clinical trial:

Trial Title: Peri-operative Aspirin Continuation Versus Discontinuation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adults aged 18 years and older with the ability for self-consent,~* referred for elective TURBT,~* receiving low-dose daily Aspirin prophylaxis.~Exclusion Criteria:~* known coagulopathy or abnormal coagulation profile (prothrombin time, partial thromboplastin time, or platelet count),~* receiving other anti-thrombotic, anti-coagulant, or non-steroidal anti-inflammatory medication (NSAIDs),~* pregnancy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Aspirin continuation (Type: ACTIVE_COMPARATOR): Continued use of Acetylsalicylic acid at prior dosage (75mg or 100mg tablet one-per-day).
- Aspirin discontinuation (Type: NO_INTERVENTION): Discontinuation of Acetylsalicylic acid ten days prior to surgery, and re-initiation two weeks after hospital discharge.

Based on this trial design, predict the completion outcome and termination type (if applicable).